Back to Search
Start Over
Correlation between Stroke Risk and Systolic Blood Pressure in Patients over 50 Years with Uncontrolled Hypertension: Results from the SYSTUP-India Study.
- Source :
-
Cardiovascular therapeutics [Cardiovasc Ther] 2021 Jun 28; Vol. 2021, pp. 6622651. Date of Electronic Publication: 2021 Jun 28 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Objectives: To assess mean systolic and diastolic blood pressure (SBP and DBP) levels in patients ≥50 years with uncontrolled hypertension (HTN) and evaluate the correlation between BP and stroke risk. It also assessed therapeutic drug classes prescribed in these patients.<br />Methods: A cross-sectional, observational study was conducted at 176 outpatient centers across India, including patients aged ≥50 years with elevated SBP (≥140 mmHg). The relationship between stroke risk, calculated using Stroke Riskometer™, and mean SBP, mean DBP, and other risk factors was evaluated using Pearson correlation coefficient and logistic regression analysis.<br />Results: The study included 3791 patients (men, 60.0%; mean age: 62.1 ± 8.3 years; mean BMI: 27 kg/m <superscript>2</superscript> ) with mean SBP 157.3 ± 12.8 mmHg and mean DBP 89.8 ± 9.7 mmHg. Five-year stroke risk in 33.9% and 10-year stroke risk in 70% patients were moderate to severe. A ~4% increase in both 5- and 10-year stroke risk with each 1 mmHg increase in mean SBP ( p < 0.0001) was seen. However, mean DBP did not exhibit any significant correlation with 5-year ( p = 0.242) or 10-year ( p = 0.8038) stroke risk. There was a positive correlation between mean SBP and patient age, comorbid diabetes, and smoking and alcohol habits ( p < 0.0001). Comorbid diabetes and smoking increased 5- and 10-year stroke risk by 2- to 5-fold. Irrespective of the risk category, most patients received antihypertensive therapy with an angiotensin receptor blocker.<br />Conclusion: Findings corroborate an association between stroke risk and mean SBP. These real-world clinical findings indicate that efforts are required to improve primary prevention of stroke and reduce the prevalence of recurrent stroke in India.<br />Competing Interests: Dr. Preeti Nikam, Dr. Minakshi Jaiswal, and Dr. Nishita Shah are employees of Serdia Pharmaceuticals (India) Pvt. Ltd. All other authors have no conflicts of interest.<br /> (Copyright © 2021 Rishi Sethi et al.)
Details
- Language :
- English
- ISSN :
- 1755-5922
- Volume :
- 2021
- Database :
- MEDLINE
- Journal :
- Cardiovascular therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 34257706
- Full Text :
- https://doi.org/10.1155/2021/6622651